Glycemic and insulinemic responses of nondiabetic healthy adult subjects to an experimental acid-induced viscosity complex incorporated into a glucose beverage.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 12093442)

Published in Nutrition on July 02, 2002

Authors

Bryan W Wolf1, Chron-Si Lai, Mark S Kipnes, Deborah G Ataya, Keith B Wheeler, Bradley A Zinker, Keith A Garleb, Jeffrey L Firkins

Author Affiliations

1: Ross Products Division of Abbott Laboratories, 625 Cleveland Avenue, Columbus, OH 43215-1724, USA. bryan.wolf@rossnutrition.com

Articles by these authors

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care (2006) 4.91

Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 2.64

Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol Cancer Ther (2005) 2.15

Development of an assay to quantify rumen ciliate protozoal biomass in cows using real-time PCR. J Nutr (2004) 2.13

Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain (2012) 1.94

Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther (2010) 1.22

Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes (2003) 1.19

Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes (2002) 1.07

Single-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy volunteers and patients with type 2 diabetes mellitus. J Clin Pharmacol (2010) 1.05

An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol (2005) 1.03

Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy. Diab Vasc Dis Res (2006) 0.96

PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat. Mol Cell Endocrinol (2003) 0.95

Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice. Mol Endocrinol (2003) 0.95

Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol (2004) 0.94

Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors. J Med Chem (2006) 0.90

Inclusion of guar gum and alginate into a crispy bar improves postprandial glycemia in humans. J Nutr (2004) 0.89

Fructooligosaccharides and Lactobacillus acidophilus modify gut microbial populations, total tract nutrient digestibilities and fecal protein catabolite concentrations in healthy adult dogs. J Nutr (2002) 0.88

Fructooligosaccharides and Lactobacillus acidophilus modify bowel function and protein catabolites excreted by healthy humans. J Nutr (2002) 0.84

Metabolic responses with endothelin antagonism in a model of insulin resistance. Metabolism (2005) 0.83

Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitors. J Med Chem (2006) 0.83

Quantifying the responses of mixed rumen microbes to excess carbohydrate. Appl Environ Microbiol (2013) 0.82

Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit. Bioorg Med Chem Lett (2007) 0.81

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther (2004) 0.81

Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem (2006) 0.81

Direct determination of methionine sulfoxide in milk proteins by enzyme hydrolysis/high-performance liquid chromatography. J Chromatogr A (2007) 0.80

Evaluation of methods to detect changes in reserve carbohydrate for mixed rumen microbes. J Microbiol Methods (2013) 0.79

Pullulan is a slowly digested carbohydrate in humans. J Nutr (2003) 0.78

Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats. Metabolism (2005) 0.78

A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections. J Diabetes Sci Technol (2011) 0.78

Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway. J Pharmacol Exp Ther (2007) 0.78

Metabolic responses in a model of insulin resistance: comparison between oral glucose and meal tolerance tests. Metabolism (2002) 0.78

Development of insulin resistance and endothelin-1 levels in the Zucker fatty rat. Metabolism (2003) 0.78

Effect of a viscous fiber-containing nutrition bar on satiety of patients with type 2 diabetes. Diabetes Res Clin Pract (2006) 0.77

Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes. J Med Chem (2006) 0.76

Supplemental fructose attenuates postprandial glycemia in Zucker fatty fa/fa rats. J Nutr (2002) 0.76

Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B. J Med Chem (2003) 0.75

Reduction of PTP1B induces differential expression of PI3-kinase (p85alpha) isoforms. Biochem Biophys Res Commun (2004) 0.75